Zoetis Inc. $ZTS Shares Acquired by AlphaQuest LLC

AlphaQuest LLC boosted its position in Zoetis Inc. (NYSE:ZTS) by 402.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,608 shares of the company’s stock after purchasing an additional 11,699 shares during the period. AlphaQuest LLC’s holdings in Zoetis were worth $2,137,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC boosted its stake in Zoetis by 496.6% during the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after buying an additional 144 shares in the last quarter. REAP Financial Group LLC lifted its holdings in Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock valued at $31,000 after acquiring an additional 131 shares during the last quarter. NewSquare Capital LLC lifted its holdings in Zoetis by 69.1% in the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after acquiring an additional 85 shares during the last quarter. Financial Consulate Inc. bought a new position in shares of Zoetis during the 3rd quarter valued at about $39,000. Finally, SJS Investment Consulting Inc. grew its stake in shares of Zoetis by 1,606.3% in the 3rd quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock worth $40,000 after purchasing an additional 257 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. BTIG Research restated a “buy” rating and set a $160.00 target price on shares of Zoetis in a report on Wednesday, December 3rd. HSBC set a $140.00 price objective on Zoetis in a research note on Wednesday, December 10th. KeyCorp began coverage on Zoetis in a report on Thursday, November 20th. They issued a “sector weight” rating on the stock. Weiss Ratings downgraded Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Finally, Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $152.45.

Zoetis Price Performance

Shares of NYSE:ZTS opened at $124.79 on Friday. The company’s fifty day moving average is $124.08 and its two-hundred day moving average is $137.26. The company has a quick ratio of 2.28, a current ratio of 3.64 and a debt-to-equity ratio of 1.31. Zoetis Inc. has a 12-month low of $115.25 and a 12-month high of $177.40. The company has a market cap of $54.99 billion, a P/E ratio of 21.01, a price-to-earnings-growth ratio of 2.10 and a beta of 0.97.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping the consensus estimate of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.Zoetis’s revenue was up .5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.58 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be paid a dividend of $0.53 per share. This is a boost from Zoetis’s previous quarterly dividend of $0.50. The ex-dividend date of this dividend is Tuesday, January 20th. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s dividend payout ratio (DPR) is presently 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.